| Table 2. Information on national evaluations providing data to the Interbull | ||||||
| routine evaluation for milk somatic cells, as provided by participating countries | ||||||
|
proof |
||||||
| Country | Breed(s) | h2 | model | unit* |
expression** |
|
| Canada | AYS | .25 | AM TD | SCS(2) | TA | |
| BSW | .26 | -"- | -"- | -"- | ||
| GUE | .33 | -"- | -"- | -"- | ||
| HOL | .29 | -"- | -"- | -"- | ||
| JER | .26 | -"- | -"- | -"- | ||
| Denmark | AYS HOL JER | .11 | SM MT | SCC | TA | |
| Estonia | HOL | .12 | AM TD | SCS(2) | RBV(-) | |
| Finland | AYS HOL | .15 | AM | SCS(e) | RBV(-) | |
| France | BSW HOL | .15 | AM | SCS(2) | RBV(-) | |
| Germany | HOL | .20 | AM TD | SCS(2) | BV | |
| Israel | HOL | .10 | AM | SCS(2) | TA | |
| Italy | HOL | .08 | AM TD | SCS(2) | RBV(-) | |
| Netherlands | BSW HOL JER | .15 | AM | SCS(2) | RTA(-) | |
| Sweden | AYS HOL | .08 | SM | SCC(10) | RBV(-) | |
| Switzerland | HOL | .31 | AM TD | SCS(2) | BV | |
| United Kingdom | AYS GUE HOL JER | .11 | AM | SCC(e) | TA | |
| United States | AYS BSW GUE HOL JER | .10 | AM | SCS(2) | TA | |
| *log-base used indicated within parenthesis | ||||||
| **reversed scale, i.e. high values are desirable, indicated within parenthesis | ||||||